RMC No. 17-2024 — Publishing the full text of the November 29, 2023 letter from the Food and Drug Administration of the Department of Health endorsing updates to the List of VAT-Exempt Products under Republic Act (RA) No. 10963 (TRAIN Law) and RA No. 11534 (CREATE Act) Digest | Full Text | Annex A

BUREAU OF INTERNAL REVENUE REPUBLIC OF THE PHILIPPINES DEPARTMENT OF FINANCE

JAN 2 6 2024

REVENUE MEMORANDUM CIRCULAR NO. /7- &024

SUBJECT : Publishing the Full Text of the November 29,2023 Letter from the Food and

No. 10963 (TRAIN Law) and R.A.No.11534 (CREATE Act) Updates to the List of VAT-Exempt Products Under Republic Act (R.A.) Drug Administration (FDA) of the Department of Health (DOH) Endorsing

TO : All Internal Revenue Officers and Others Concerned

Under R.A. No. 11534 or the CREATE Act, particularly the following: concerned, attached is the November 29, 2023 letter (Annex "A") from Dr. Samuel A. Zacate Director General of the FDA, for an update to the published List of VAT-Exempt Medicines For the information and guidance of all internal revenue officers, employees and others

1. Inclusion of certain medicines for cancer, diabetes, hypertension, kidney disease, mental illness, and tuberculosis; and

2. Deletion of medicine for hypertension.

exemption of the covered medicines and medical devices under the CREATE Act shall be on As clarified under Q&A No. 1 of RMC No. 99-2021, the effectivity of the VAT

the date of publication by the FDA of the updates to the said list.

All concerned are hereby enjoined to be guided accordingly and give this Circular as wide a publicity as possible.

VAGUI,JR Inissioner of Internal Revenue

B T I HNICATIDASL ?NA BUREAU OF INTERNALREVENUE

S IANAO JAN 2 6 2024 CORONA 9 Q4X e S

RECGMS mG[.DIVISION